TDS Pharm Co (XKRX:464280) Total Inventories : ₩2,493 Mil (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co Total Inventories?

TDS Pharm Co's total inventories for the quarter that ended in Dec. 2023 was ₩2,493 Mil. TDS Pharm Co's average total inventories from the quarter that ended in Dec. 2022 to the quarter that ended in Dec. 2023 was ₩2,328 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. TDS Pharm Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was ₩2,416.28.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. TDS Pharm Co's Days Inventory for the six months ended in Dec. 2023 was 19.22.

Inventory Turnover measures how fast the company turns over its inventory within a year. TDS Pharm Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 9.50.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. TDS Pharm Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.08.

TDS Pharm Co Total Inventories Historical Data

The historical data trend for TDS Pharm Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TDS Pharm Co Total Inventories Chart

TDS Pharm Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Inventories

1,739.43

1,938.89

2,162.64

2,492.87

TDS Pharm Co Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
Total Inventories	1,739.43	1,938.89	2,162.64	2,492.87

TDS Pharm Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

TDS Pharm Co (XKRX:464280) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

TDS Pharm Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(15136.063	+	0.75 * 6575.33	+	0.5 * 2492.868	-	11025.465
-	0	-	0)	/	4.258
=	2,416.28

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

TDS Pharm Co's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	2327.752	/	22108.243	*	365 / 2
	=	19.22

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

TDS Pharm Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	22108.243	/	2327.752
	=	9.50

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

TDS Pharm Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	2327.752	/	30049.355
	=	0.08

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

TDS Pharm Co Total Inventories Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines